O T C
ALYI Chooses Bigger Investment Market With Less Competition

Dallas, TX – September 1, 2020 – OTC PR WIRE – Alternet Systems, Inc. (OTC PINK: ALYI), in advance of a funding release schedule for tomorrow from its investment partner RevoltTOKEN (www.revolttoken.com), announced today its optimism in the success of both realizing its $100 million funding object through RevoltTOKEN’s upcoming ICO, and exceeding far beyond

DGDM’s Disruptive Pesticide Product Targeted to MJ Growers Passes Testing Trials During Pre-EPA Certification Period

FLOWER MOUND, TX, September 1, 2020 — OTC PR WIRE — Digital Development Partners, Inc. (OTC PINK: DGDM) (which will become Black Bird Potentials Inc.), exclusive distributor of MiteXstream biopesticide and manufacturer of Grizzly Creek Naturals CBD products, today announced that its MiteXstream biopesticide had, in two separate in-the-field private industry tests, continued to display

ALYI $300 Million Electric Vehicle Revenue Outlook Could Soon Double

Dallas, TX – August 12, 2020 – OTC PR WIRE – Alternet Systems, Inc. (OTC PINK: ALYI) today announced that in reaction to recent events, its existing $300 million revenue outlook could soon double, if not go even higher. Management highlighted the recent surge in electric vehicle investment interest.  Tesla, among other notable electric vehicle

Creative Medical Technology Holdings Corporate Update

Phoenix, AZ, June 17, 2020 – Creative Medical Technology Holdings, Inc. (OTC Pink: CELZ), a leading commercial stage regenerative medicine company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today announced business updates and plans for remainder of 2020. Business Highlights Debt From January 1st, 2020 through May 31st, 2020 the company

Immune Therapeutics Announces that Equity Partner, Cytocom, Inc., has Filed an Investigational New Drug Application to Conduct a Phase II Clinical Trial Evaluating CYTO-201 Treatment in COVID-19 Patients

Winter Park, FL., June 9, 2020, – Immune Therapeutics, Inc. (OTC PINK: IMUN), announced today that equity partner, Cytocom, Inc., has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to study CYTO-201 for the treatment of COVID-19. The submission has been reviewed by the COVID-19 Scientific/Technical Triage Team

Veteran Telehealth Platform, Net Medical, Introduces Frictionless, 1-click Experience to Make Provider Specialties More Accessible to Rural, Regional, Pandemic-hit Populations

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical’s new features reduce healthcare waste, inefficiencies and access blocks ALBUQUERQUE, N.M. (June 3, 2020) — Net Medical., (OTC PINK: NMXS), a global telehealth platform and premier provider of online medical services and support, today announced a suite of new

ALYI Publishes Q1 2020 Financial RPT And Schedules Mgmt. Update To Include 2020 Outlook

Dallas, TX – May 21, 2020 – Alternet Systems, Inc. (OTC PINK: ALYI) today announced publishing its Q1 2020 financial report. The company also published its 2019 annual financial report. Both reports show the company’s base revenue has not been impacted by the Covid-19 pandemic. ALYI management further confirms that its $300 million African electric

Contact Us

  • 707-OTC-WIRE (707-682-9473)
  • cs@otcprwire.com

All Rights Reserved © 2019